« Previous
Next »
Journal of Vascular Surgery
Volume 50, Issue 4
, Pages
769-775
, October 2009
Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia
-
Kaplan-Meier curves demonstrating amputation-free (AF) survival stratified according to each patient's calculated risk score (Vascular Study Group of Northern New England [VSGNNE] cohort).
Kaplan-Meier curves demonstrating amputation-free (AF) survival stratified according to each patient's calculated risk score (Vascular Study Group of Northern New England [VSGNNE] cohort).
-
Validation of the PREVENT III (PIII) critical limb ischemia (CLI) risk score in 4 different datasets (3286 patients)—PIII derivation set, PIII validation set, retrospective validation set, prospective
Validation of the PREVENT III (PIII) critical limb ischemia (CLI) risk score in 4 different datasets (3286 patients)—PIII derivation set, PIII validation set, retrospective validation set, prospective Vascular Study Group of Northern New England (VSGNNE) validation set. AF, Amputation-free.
-
PREVENT III (PIII) critical limb ischemia (CLI) risk score was an effective tool for discriminating three significant strata of risk when tested on the following endpoints: perioperative major adversePREVENT III (PIII) critical limb ischemia (CLI) risk score was an effective tool for discriminating three significant strata of risk when tested on the following endpoints: perioperative major adverse cardiac event (MACE) (a), perioperative and 1-year mortality (b), and 1-year ability to ambulate (c).
Competition of interest: none.
PII: S0741-5214(09)01191-4
doi: 10.1016/j.jvs.2009.05.055
© 2009 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Vascular Surgery
Volume 50, Issue 4
, Pages
769-775
, October 2009
